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Electrophysiological findings in patients with isolated left
ventricular non-compaction
Abstract
AIMS: Patients with isolated left ventricular non-compaction (IVNC) are at high risk for developing
ventricular tachyarrhythmias. However, no analysis of invasive electrophysiological (EP) findings in
these patients has yet been performed. METHODS AND RESULTS: We performed a retrospective
analysis of EP findings in 24 patients with IVNC. Ventricular tachyarrhythmias were inducible in nine
patients; of these, two patients had sustained monomorphic ventricular tachycardia (VT) and two
patients had ventricular fibrillation. No specific electrocardiographic or echocardiographic finding was
predictive of VT inducibility. Three of the 9 patients with inducible VT experienced ventricular
tachyarrhythmias during the follow-up of 61.4+/-50 months, whereas no tachyarrhythmias or sudden
deaths were noted in 12 patients without inducible VT during the follow-up of 30+/-19 months (3
patients in the latter group were lost to follow-up). Supraventricular tachyarrhythmias were inducible in
seven patients. CONCLUSION: Our present study provides the first comprehensive analysis of EP
findings in patients with IVNC. Ventricular and supraventricular arrhythmias can readily be induced in
these patients, whereas the inducibility of a sustained monomorphic VT is relatively low. Further studies
including long-term follow-up are required to investigate the role of EP testing for arrhythmic risk
stratification in these patients.
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Abstract 
 
Background – Patients with isolated left ventricular noncompaction (IVNC) are at high risk for 
developing ventricular tachyarrhythmias. However, no analysis of invasive electrophysiologic (EP) 
findings in these patients has yet been performed.   
Methods and Results – We performed a retrospective analysis of EP findings in 24 patients with 
IVNC. Ventricular tachyarrhythmias were inducible in 9 patients; of these, 2 patients had sustained 
monomorphic ventricular tachycardia (VT) and 2 patients had ventricular fibrillation. No specific 
electrocardiographic or echocardiographic finding was predictive of VT inducibility. Three of the 9 
patients with inducible VT experienced ventricular tachyarrhythmias during the follow-up of 61.4 ± 
50 months, while no tachyarrhythmias or sudden deaths were noted in 12 patients without inducible 
VT during the follow-up of 30 ± 19 months (3 patients in the latter group were lost to follow-up). 
Supraventricular tachyarrhythmias were inducible in 7 patients.  
Conclusions – Our present study provides the first comprehensive analysis of EP findings in 
patients with IVNC. Ventricular and supraventricular arrhythmias can readily be induced in these 
patients, while the inducibility of a sustained monomorphic VT is relatively low. Further studies 
including long-term follow-up are required to investigate the role of EP testing for arrhythmic risk 
stratification in these patients. 
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Condensed Abstract 
 
We performed the first comprehensive analysis of electrophysiologic findings in 24 patients with 
isolated left ventricular noncompaction. Importantly, we show that ventricular and supraventricular 
arrhythmias can readily be induced during EP testing, while the inducibility of a sustained 
monomorphic ventricular tachycardia is relatively low.  
 
 
 
 
 
Keywords:  Noncompaction, Cardiomyopathy, Electrophysiology, Ventricular Tachycardia, 
Implantable Cardioverter Defibrillator 
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Introduction 
 
 Isolated left ventricular noncompaction (IVNC) is a primary genetic cardiomyopathy,1 
which is morphologically characterized by a two-layered structure of the myocardium consisting of 
a compacted, thin epicardial layer and a non-compacted, severely thickened endocardial layer, 
which by definition occur in the absence of other coexisting congenital lesions.2, 3 The clinical 
spectrum of presentation of these patients is highly variable, ranging from asymptomatic, 
coincidental discovery of the disease to severe heart failure.3, 4  
IVNC is a rare disorder: In a large series of patients referred to a tertiary care 
echocardiography laboratory, the prevalence of IVNC was 0.014%;5 in a single center heart failure 
clinic, IVNC was the underlying cause of heart failure in 2.7% and heart transplantation in 2% of 
patients.6 However, both benign as well as life-threatening arrhythmias such as ventricular 
tachycardia (VT) and ventricular fibrillation (VF) have been reported in patients with IVNC.4, 7 For 
the prevention of cardiac sudden death, implantation of an implantable cardioverter-defibrillator 
(ICD) may be considered; indeed, we recently reported on 12 patients with IVNC who received an 
ICD either for primary or secondary prevention.8 However, as IVNC is a rare disorder, it is unclear 
at present under which circumstances such arrhythmias are most likely to occur. Invasive 
electrophysiologic (EP) studies are frequently used to assess the propensity for developing 
malignant ventricular tachyarrhythmias. To date, however, EP findings in patients with IVNC have 
not been comprehensively analyzed. The purpose of the present retrospective analysis, therefore, 
was to characterize the electrophysiological properties in our relatively large cohort of patients with 
IVNC.  
 
 
Methods 
 
Study population  
Between January 1998 and November 2008, an EP study was performed in 20 patients with 
IVNC at the University Hospital Zurich, and 4 patients at the Cantonal Hospital Lucerne. Seven of 
these cases, who subsequently underwent ICD implantation, were previously reported.8  
Echocardiographic criteria for the diagnosis of IVNC were the same as previously published 
and remained unchanged during the entire study period:3-5 1) The absence of coexisting cardiac 
anomalies (other than 2–4); 2) Two-layered structure of the myocardium with a thick, non-
compacted endocardial layer consisting of a trabecular meshwork with deep endocardial spaces and 
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a much thinner, compacted epicardial layer, and a maximum end-systolic ratio of the non-
compacted endocardial layer to the compacted myocardium of ≥2, measured at end-systole; 3) 
Predominant segmental location of the abnormality; and 4) Colour Doppler-echocardiographic 
evidence that deep intertrabecular recesses are perfused with blood from the left ventricular cavity. 
Of note, the diagnosis of “right ventricular non-compaction” is not attempted anymore at our 
institutions, as a differentiation between normal variants of the usually highly trabeculated right 
ventricle and pathological forms may be difficult if not impossible.3, 5, 9 Furthermore, patients not 
fulfilling criteria of isolated non-compaction cardiomyopathy (i.e., IVNC in the presence of other 
congenital heart diseases) were also excluded from the analysis. All patients underwent a complete 
echocardiographic examination at first presentation; mean time between echocardiography and EP 
study was 2.1 ± 2.9 months. ECGs at the time of the EP study were independently analyzed by two 
readers (JS and FD). 
 
Electrophysiologic study  
EP studies were performed according to a standard protocol using 6F diagnostic 
electrophysiology catheters (Bard Inc., Lowell, MA) on a Bard EP lab with a Micropace EPS 320 
Cardiac Stimulator System (Micropace, Tustin CA). All antiarrhythmic drugs were discontinued 5 
half-lives before the electrophysiologic study. Programmed ventricular stimulation protocol 
included 3 drive-cycle lengths and 3 ventricular extrastimuli while pacing from 2 right ventricular 
sites (apex and outflow tract). Ventricular stimulation was performed until refractoriness or until a 
minimum coupling interval of 180 ms. In patients in whom VT was not inducible at baseline, 
isoproterenol (Hospira Enterprises, Hoofddorp, The Netherlands) was administrated intravenously 
(up to 4 μg/min), followed by application of up to three extrastimuli as well as burst pacing (until a 
minimum of 250ms) if deemed clinically indicated by the operator. 
Sustained VT was defined as tachycardia of ventricular origin lasting longer than 30 seconds 
or resulting in hemodynamic compromise; non-sustained VT was defined as a tachycardia of 
ventricular origin of more than 3 beats but less than 30 seconds, and not resulting in hemodynamic 
compromise. Programmed stimulation in the atrium was performed using an electrode positioned in 
the high right atrium. Sinus node recovery time (SNRT) was measured after overdrive pacing in the 
high right atrium for 30 seconds; corrected SNRT was calculated by subtracting the individual 
patient’s basic cycle length (BCL) from the measured SNRT. 
 
 
 
5 / 21 
Steffel et al.: EP findings in IVNC (EUPC-D-09-00213 – R2) 
Statistics 
Comparison of categorical variables was performed by Fisher's exact test. Continuous 
variables were analyzed by two-sided Student’s t-test (for normally distributed variables) or Mann-
Whitney U test (for non-normally distributed variables) and are presented as mean ± standard 
deviation. A p-value < 0.05 was considered significant. Statistical analysis was performed using 
GraphPad Prism 4 for Windows (GraphPad Software Inc, La Jolla, CA). 
 
 
Results 
 
Baseline parameters and indication for EP study 
Baseline characteristics and indications for the invasive EP study are summarized in table 1. 
Most frequently, EP testing was performed for the evaluation of syncope, documented VT,  
symptomatic ventricular extrasystoles (VES), or for arrhythmic risk stratification. Since no 
guidelines or recommendations with respect to EP testing in IVNC exist, the decision to perform an 
EP study was made on an individual basis and according to the treating physician’s judgment. 
An entirely normal EP study was found in 11 patients (46%). While these patients were 
significantly younger (25 ± 9.8 vs. 46.3 ± 12.8 years, p<0.001), no other clinical, 
electrocardiographic or echocardiographic parameters were predictive of a normal EP study. 
 
Rhythm at EP study and atrioventricular conduction 
 The underlying rhythm at the time of the EP study as well as atrioventricular conduction 
properties are summarized in table 2. Most patients presented with sinus rhythm; 2 patients had 
ventricular preexcitation via an accessory pathway. High degree AV block was present in 2 
patients; one of these patients had a pacemaker in place with a slow escape rhythm showing a His 
potential before each QRS complex (indicating location of the AV block proximal to the bundle of 
His), while the other had underlying atrial fibrillation with a junctional escape rhythm. One patient 
had evidence of dual AV nodal physiology with a reproducible jump in AH conduction, but without 
inducible AV nodal reentry tachycardia (AVNRT). The HV interval was slightly prolonged in one 
patient (58 ms), while one patient had a rather short AV block cycle length of 225 ms. There was no 
evidence of sinus node disease in any of the patients examined. 
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Inducibility of ventricular tachyarrhythmias 
 Type and origin of VT, ease of inducibility, concomitant ECG, echocardiographic and 
clinical findings (evidence of coronary artery disease, Holter ECG findings, signs of heart failure, 
heart failure or antiarrhythmic medication at the time of EP study, if available) are summarized in 
table 3. Ventricular tachyarrhythmias were inducible in 9 patients (38%). Two patients had 
sustained monomorphic VT (Fig. 1), 2 patients had sustained polymorphic VT or VF, whereas the 
remaining 5 patients had non-sustained polymorphic VT. One of the latter patients (patient 6, Tab. 
3) had a monomorphic sustained VT originating from the right ventricular outflow tract (RVOT) at 
initial presentation. No specific electrocardiographic or echocardiographic finding was predictive of 
VT inducibility during EP testing. The prevalence of significant coronary artery disease was low, 
both in patients with (Tab. 3) and without (Tab. 4) inducible VT. 
Since no guidelines or recommendations regarding ICD implantation in patients with IVNC 
exist, this decision was left to the discretion of the treating physician. In our cohort, 7 of the 9 
patients who had inducible VT or VF underwent ICD implantation following the EP study. In 
contrast, non-sustained VT in the EP study of 2 patients was judged to be nonspecific, and therefore 
these patients did not have an ICD implanted. 3 of the 9 patients with an inducible VT showed 
evidence of ventricular tachyarrhythmias during the mean follow-up period of 61 ± 50 months, all 
of which were adequately treated with either anti-tachycardia pacing or shock delivery.  
 Clinical parameters, resting ECG and echocardiographic findings of the 15 patients (63%) 
without inducible ventricular arrhythmias are summarized in table 4. Three of the 15 patients 
without inducible ventricular tachyarrhythmias were lost to follow-up; mean follow-up of the 
remaining 12 patients was 30 ± 19 months. During this period, no symptomatic tachyarrhythmias 
were reported.  
 
Inducibility of supraventricular tachyarrhythmias and therapeutic interventions 
 Supraventricular tachyarrhythmias were inducible in 7 patients (Tab. 2). In 2 patients, an 
orthodromic AV reentry tachycardia (AVRT) was inducible; one of these patients (in whom AVRT 
was easily induced) subsequently underwent successful ablation of a left anterolateral accessory 
pathway, while an intervention was not performed in the other, asymptomatic patient (in whom 
AVRT was only inducible under isoproterenol infusion). One further patient had evidence of a right 
anterior accessory pathway (without inducible AVRT during the EP study), which was 
subsequently ablated. AVNRT was induced in one patient under isoproterenol infusion, who 
subsequently underwent successful slow pathway modification. In one patient who presented with 
typical atrial flutter, the tricuspid isthmus was ablated successfully. Of the two patients with 
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inducible atrial fibrillation, one was induced by singular atrial stimulation while the other occurred 
under isoproterenol infusion. 
 
 
Discussion 
 
This is the first study to report the electrophysiological characteristics in a large cohort of 
patients with IVNC. This rare disease is known to be associated with life threatening ventricular 
tachyarrhythmias possibly due to the noncompacted myocardium serving as the arrhythmic 
substrate. Furthermore, impaired flow reserve in structurally compacted myocardial segments with 
resultant (intermittent) ischemia may play an important role.10 Indeed, previous studies have 
reported ventricular arrhythmias in 47%, and sudden cardiac death in as many as 18% of (mostly) 
adult patients with IVNC.5, 8, 9 In our cohort, however, a sustained monomorphic VT was only 
rarely induced, and only two patients had inducible polymorphic VT/VF. Moreover, infusion of 
isoproterenol did not facilitate the induction of sustained monomorphic tachycardia. Non-sustained 
polymorphic ventricular tachycardia was observed more commonly, which in general is believed to 
be a nonspecific finding, especially under isoproterenol infusion and/or application of three 
extrastimuli or burst pacing. However, we deliberately chose this protocol in view of the high 
propensity of patients with IVNC to develop malignant ventricular arrhythmias and sudden death. 
Indeed, two such patients (patient 4 and 5, Tab. 4) subsequently demonstrated ventricular 
arrhythmias on follow-up, which were adequately treated by their ICDs. No specific clinical, 
electrocardiographic or echocardiographic finding was predictive of VT inducibility or of a normal 
EP study (except for the younger age of patients in the latter group). It is of note, however, that 
none of the patients with an EF more than 50% developed spontaneous VT during follow-up.  
One patient (patient 1, Tab. 3) with an inducible VT demonstrated a severely reduced 
systolic left ventricular function, which in itself is known to increase the propensity for developing 
ventricular tachyarrhythmias. Based on current evidence, patients with a severely reduced  left 
ventricular EF have an ICD implanted empirically and do not undergo EP testing for risk 
stratification. However, several of our patients (including patient 1, Tab. 3) underwent EP testing 
before the advent of landmark studies such as the SCD-HeFT trial. Since IVNC is a rare disorder, it 
is unclear whether currently available guidelines are also applicable to this patient population. 
Nevertheless, prophylactic ICD implantation without prior EP study nowadays appears to be 
reasonable in patients with IVNC who fulfill the SCD-HeFT criteria. 
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In our study, six patients did not have any clinical signs or predictors of ventricular 
tachyarrhythmias prior to the EP study, and underwent EP testing for risk stratification in view of 
the increased risk of ventricular arrhythmias in this patient population. A sustained monomorphic 
VT could be induced in one of these patients (patient 2, Tab. 4), while the others had normal EP 
studies. In contrast, one patient had a sustained monomorphic VT originating from the RVOT at 
presentation, which was not reproducible during EP testing. We cannot exclude the possibility of a 
non-reentrant mechanism for the induction of the monomorphic tachycardia in this particular 
patient. Furthermore, it cannot be excluded that RVOT tachycardia was unrelated to the presence of 
IVNC in this patient.  
No ventricular arrhythmias or sudden cardiac deaths were recorded in the clinical follow-up 
of 12 patients in whom no VT was inducible on EP testing. Two of these patients also had an ICD 
implanted, which showed no arrhythmic events during follow-up. These data indicate that a 
negative EP study may identify a subset of patients with IVNC at low risk of developing malignant 
tachyarrhythmias.  However, follow-up duration in this subgroup was considerably shorter (i.e., 30 
months) as compared to that of patients with inducible VT (i.e., 61 months). Indeed, a VT occurred 
in one patient from the latter group 8 years after EP testing, indicating that malignant arrhythmic 
events may occur outside the 30 months follow-up period for patients without inducible VT. 
Furthermore, this observation raises the possibility that progression of the disease (and hence 
change of the arrhythmogenic substrate) may be an important factor contributing to the propensity 
of developing malignant VT, especially in the long term. Hence, further studies are warranted to 
determine the role of EP testing in IVNC, especially with respect to the prospective value of a 
negative EP study in these patients.  
 Intraventricular conduction delay as well as first-degree AV block are common in patients 
with IVNC.3-5 Interstitial fibrosis and subendocardial fibroelastosis, which are frequently found on 
endomyocardial biopsies in these patients, may be the underlying pathoanatomic correlate.11 In 
addition, sinus bradycardia was frequently observed in children with IVNC.12 In our patient cohort, 
abnormal AV conduction was discovered in several patients. Interestingly, in both patients with 
complete heart block, the conduction block was at the supra-His level.  
Wolf-Parkinson-White (WPW) syndrome is equally a common finding in the pediatric 
population with IVNC and present in up to 17% of these children,13 while it is rarely found in 
adults.3, 4 Accessory AV pathways are most likely the result of persisting AV muscular continuity 
having failed to regress during embryogenesis, which appears pathophysiologically similar to the 
failure of regression of the non-compacted myocardium in IVNC.11 However, the prevalence of 
WPW in the general population is approximately 0.15-0.2%, and the coexistence of WPW and 
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IVNC may have simply occurred by chance. In our cohort, a total of 7 patients (29%) with IVNC 
had at least one supraventricular tachycardia, which included atrial fibrillation and atrial 
tachycardia. It remains to be determined if this developmental disease of the myocardium also plays 
an important role in atrial arrhythmogenesis. 
Limitations: The goal of our present study was to comprehensively analyze invasive EP 
findings in patients with IVNC. Although our cohort of patients with this rare disorder undergoing 
EP testing is the largest reported so far, the study is limited by several factors. The unequal follow-
up duration of patients without (30 months) and with inducible VT (61 months) makes a recurrent 
VT more likely in the latter group simply due to the longer length of follow up. Further limitations 
include a low absolute number of cases as well as a possible selection bias, since an EP study was 
only performed in patients in whom it was deemed clinically indicated by the treating physician. In 
addition, three patients without inducible VT were lost to follow-up. 
 
 
Conclusion 
 
Ventricular as well as supraventricular arrhythmias can readily be induced during EP testing 
in patients with IVNC, while the inducibility of a sustained monomorphic VT is relatively low.  Our 
data further indicate that in selected high-risk patients, EP testing may be of limited value, and ICD 
implantation may be considered in patients with IVNC clinically judged to be at high risk for 
ventricular tachyarrhythmias. These include patients with a prior history of sustained VT or VF, or 
patients fulfilling well-established primary prevention criteria for ICD implantation. Additional 
studies including (prospective) long-term follow-up are required to  investigate the role of EP 
testing for arrhythmic risk stratification, especially in patients without inducible VT. 
 
 
 
 
 
 
10 / 21 
Steffel et al.: EP findings in IVNC (EUPC-D-09-00213 – R2) 
Conflict of Interest Disclosure 
 
None of the authors report a conflict of interest. 
 
 
11 / 21 
Steffel et al.: EP findings in IVNC (EUPC-D-09-00213 – R2) 
References 
 
1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. 
Contemporary definitions and classification of the cardiomyopathies: an American Heart 
Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure 
and Transplantation Committee; Quality of Care and Outcomes Research and Functional 
Genomics and Translational Biology Interdisciplinary Working Groups; and Council on 
Epidemiology and Prevention. Circulation. 2006;113:1807-1816. 
2. Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and 
pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards 
classification as a distinct cardiomyopathy. Heart. 2001;86:666-671. 
3. Jenni R, Oechslin EN, van der Loo B. Isolated ventricular non-compaction of the 
myocardium in adults. Heart. 2007;93:11-15. 
4. Steffel J, Kobza R, Oechslin E, Jenni R, Duru F. Electrocardiographic Characteristics at 
Initial Diagnosis in Patients with Isolated Left Ventricular Noncompaction. American 
Journal of Cardiology. 2009; in press. 
5. Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R. Long-term follow-up 
of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with 
poor prognosis. J Am Coll Cardiol. 2000;36:493-500. 
6. Kovacevic-Preradovic T, Jenni R, Oechslin EN, Noll G, Seifert B, Attenhofer Jost CH. 
Isolated left ventricular noncompaction as a cause for heart failure and heart 
transplantation: a single center experience. Cardiology. 2009;112:158-164. 
7. Duru F, Candinas R. Noncompaction of ventricular myocardium and arrhythmias. Journal 
of cardiovascular electrophysiology. 2000;11:493. 
8. Kobza R, Jenni R, Erne P, Oechslin E, Duru F. Implantable cardioverter-defibrillators in 
patients with left ventricular noncompaction. Pacing Clin Electrophysiol. 2008;31:461-
467. 
9. Ritter M, Oechslin E, Sutsch G, Attenhofer C, Schneider J, Jenni R. Isolated 
noncompaction of the myocardium in adults. Mayo Clinic proceedings. 1997;72:26-31. 
10. Jenni R, Wyss CA, Oechslin EN, Kaufmann PA. Isolated ventricular noncompaction is 
associated with coronary microcirculatory dysfunction. J Am Coll Cardiol. 2002;39:450-
454. 
12 / 21 
Steffel et al.: EP findings in IVNC (EUPC-D-09-00213 – R2) 
11. Ichida F, Hamamichi Y, Miyawaki T, Ono Y, Kamiya T, Akagi T, et al. Clinical features 
of isolated noncompaction of the ventricular myocardium: long-term clinical course, 
hemodynamic properties, and genetic background. J Am Coll Cardiol. 1999;34:233-240. 
12. Celiker A, Ozkutlu S, Dilber E, Karagoz T. Rhythm abnormalities in children with isolated 
ventricular noncompaction. Pacing Clin Electrophysiol. 2005;28:1198-1202. 
13. Pignatelli RH, McMahon CJ, Dreyer WJ, Denfield SW, Price J, Belmont JW, et al. Clinical 
characterization of left ventricular noncompaction in children: a relatively common form of 
cardiomyopathy. Circulation. 2003;108:2672-2678. 
 
 
13 / 21 
Steffel et al.: EP findings in IVNC (EUPC-D-09-00213 – R2) 
Legends to Figures 
 
Figure 1:  
12-lead ECG demonstrating a sustained monomorphic tachycardia with right bundle branch block 
morphology and superior axis, indicating a left infero-apical origin. The tachycardia was induced by 
programmed electrical stimulation at the right ventricular apex with two extra stimuli. Overdrive 
pacing (see bottom V1 rhythm trace) terminated the tachycardia. 
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Figure 1: 
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Table 1: 
 
Baseline characteristics and indications for electrophysiologic testing 
 
Characteristic  
Men - no. (%) 18 (75) 
Age at diagnosis (yrs)  -  Mean (SD, range) 38.2 (±15, 16 - 63) 
Indication for EPS - no. (%)  
   Risk stratification 6 (25) 
   Syncope / presyncope 5 (21) 
   Symptomatic VES 5 (21) 
   Documented non-sustained VT 2 (8) 
   Documented sustained VT 2 (8) 
   Suspected WPW 3 (13) 
   Symptomatic atrial flutter 1 (4) 
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Table 2: 
 
Spontaneous rhythm at EP study, inducibility of supraventricular tachyarrhythmias  
and therapeutic interventions 
 
Characteristic  
Spontaneous rhythm at time of EPS - no. (%)  
   Sinus rhythm 22 (92) 
      with preexcitation 2 (8) 
   3rd degree AV block, atrial fibrillation, junctional escape rhythm 1 (4) 
   3rd degree AV block, VAD paced, junctional escape rhythm 1 (4) 
AV conduction - no. (%)  
   Normal AV node physiology 19 (79) 
   3rd degree AV block 2 (8) 
   Dual AV node physiology 1 (4) 
   Prolonged AV conduction  1 (4) 
   Supernormal AV conduction 1 (4) 
Supraventricular tachycardia inducible 7 (29) 
   AVRT (orthodromic) 2 (8) 
   Atrial fibrillation 2 (8) 
   Atrial flutter 1 (4) 
   AVNRT 1 (4) 
   Non-specific atrial tachycardia 1 (4) 
Interventions  
   Accessory pathway ablation (WPW) 2 (8%) 
   Isthmus ablation (atrial flutter) 1 (4%) 
   Slow-pathway modification (AVNRT) 1 (4%) 
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Table 3: Overview of patients with inducible ventricular arrhythmias 
ACE-I = Angiotensin converting enzyme inhibitor; AF = Atrial fibrillation; ARB = Angiotensin receptor blocker. AVB = Atrioventricular block; CAD = Coronary artery disease; 
ES = extrastimuli; G = gender; H/o = History of; inf = inferior; lat = lateral; NYHA = New York Heart Association Class; LBBB = left bundle branch block; LVEDD = Left 
ventricular enddiastolic diameter; LVEF = Left ventricular ejection fraction; LVH = left ventricular hypertrophy; Mo = Months; NC = noncompacted; nsVT = Non-sustained VT; 
post = posterior; RV = right ventricular; VES = ventricular extrasystoles; VF = ventricular fibrillation; VT = ventricular tachycardia. *This patient underwent EP testing over 10 
years ago; in the available report, the ease of inducibility is not specified, and original recordings are no longer available. 
 
Patient  EPS    ICD Follow up Resting ECG Echo   
# Age  / G 
H/o syncope, 
VT, VF Type 
Ease of 
inducibility Local. impl. Mo. Arrhythmias Abnormalities NC segments 
LVEF / 
LVEDD Other 
1 62   f 
Sustained 
VT on ECG 
Sustained, 
monomorphic VT 2 ES 
RV 
Apex Yes 102
VF after 3 years 
and several 
times afterwards
LVH with 
pathologic  
repolarisation 
Posterobasal; 
Midventricular 
lat., inf./septal;  
17% / 
4.5cm/m2 
NYHA II (ARB) 
CAD (70-80% 
RCA) 
2 44  m no 
Sustained, 
monomorphic VT 3 ES 
RV 
Apex Yes 14.6 None 
LBBB and LVH  
with secondary 
repolarisation 
abnormalities 
Basal post.; 
midventricular 
lat., post; apex 
39% / 
3.5cm/m2 
No VT on Holter 
No CAD 
Amiodarone, 
ACE-I, BB 
3 63  m 
nsVT on 
Holter ECG 
(7 beats) 
Polymorphic VT, 
degenerating into 
VF 
2 ES  RVOT Yes 9.9 None 
AF + AVB III°; 
junctional escape 
rhythm 
Midventricular 
ant., septal, 
post.; lateral 
wall; apex 
45% / 
3.2cm/m2 No CAD 
4 20  m no 
Polymorphic VT 
& VF 2 ES 
RV 
Apex Yes 121 VT after 8 years QTc 504 ms 
Infero-posterior 
wall; apex 
50% / 
2.9cm/m2 
No VT on Holter 
No CAD 
5 52  m Syncope 
Non-sustained, 
polymorphic VT 
(10s); symptomatic
3 ES RV Apex Yes 38.6
VT after 11 
months 
T-wave inversion 
V5, V6, I, avL 
Midventricular 
lat., inf.; apex 
38% / 
2.8cm/m2 
No VT on Holter 
No CAD 
6 49   f 
Sustained 
VT on ECG 
Non-sustained 
polymorphic VT      
(7 beats) 
3 ES               
(under iso-
proterenol) 
RV 
Apex Yes 29.5 None 
QTc 540ms, 
several 
polymorphic VES 
Isolated apical 50% / 2.9cm/m2 No CAD 
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7 31    f no 
Non-sustained 
polymorphic VT      
(5s) 
Not 
specified* 
RV 
Apex Yes 116 None 
Non-specific 
intraventricular 
conduction delay 
Midventricular 
lat., inf.; apex 
49% / 
3.5cm/m2 — 
8 32  m Pre-syncope 
Non-sustained 
polymorphic VT      
(7s) 
3 ES RV Apex No 111 None Normal ECG Isolated apical 
50% / 
2.9cm/m2 No VT on R-test 
9 18  m Syncope 
Non-sustained    
monomorphic VT    
(5s) 
Burst pacing  
(under iso-
proterenol) 
RVOT No 6 None U-wave Inferior and inferolateral wall
65% / 
2.5cm/m2 — 
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Table 4: Overview of patients without inducible ventricular arrhythmias 
ACE-I = Angiotensin converting enzyme inhibitor; AF = Atrial fibrillation; ARB = Angiotensin receptor blocker. AVB = Atrioventricular block; BB = Beta blocker; CAD = 
Coronary artery disease; ES = extrastimuli; G = gender; H/o = History of; inf = inferior; lat = lateral; ltf = lost to follow-up; NYHA = New York Heart Association Class; LBBB 
= left bundle branch block; LVEDD = Left ventricular enddiastolic diameter; LVEF = Left ventricular ejection fraction; LVH = left ventricular hypertrophy; Mo = Months; NC = 
noncompacted; nsVT = Non-sustained VT; post = posterior; RV = right ventricular; RVH = RV hypertrophy; VES = ventricular extrasystoles; VF = ventricular fibrillation; VT = 
ventricular tachycardia. 
 
Patient   Follow up Resting ECG Echo  Other 
# Age / G 
H/o syncope, 
VT, VF ICD Mo. 
Arrhythmias / 
Sudden death Abnormalities NC segments 
LVEF / 
LVEDD   
1 44  m 
Syncope  
(AVB III) No  11.8 No 
Normal ECG; AVB III° on rhythm 
strip 
Basal lat.; midven-
tricular ant/sept, lat., 
post.; apex 
59% / 
2.64cm/m2 — 
2 47  m No  No  17.3 No 
ST segment depression 
V5,V6,II,III,avF 
Midventricular 
ant./lat., lat., inf; 
apex 
42% / 
2.92cm/m2 
NYAH II 
(BB, ACE-I). 
No CAD 
3 25     f No  No 14.3 No 
ST segment depression V5,V6, 
II,III,avF Isolated apical 
57% / 
3.09cm/m2 
NYHA I-II; 
Holter: no VT 
4 51   m No Yes 33.2 No PQ 120ms. Normal ECG 
Basal lateral; 
midventricular 
lateral; apex 
44% / 
2.49cm/m2 NYHA II 
5 58    f No  No 28.9 No Normal ECG 
Basal lat., post; 
midventricular lat., 
post.; apex 
38% / 
3.12cm/m2 
NYHA II.     
No CAD 
6 18    m No  No 11.5 No QRS 110 ms. Voltage signs of LVH 
Midventricular sept., 
lat., inf.; apex 
63% / 
2.42cm/m2 
No VT on 
Holter 
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7 45   f No  No 27.8 No Normal ECG 
Midventricular lat.; 
apex 
60% / 
2.99cm/m2 
No VT on 
Holter 
8 20  m Syncope  No 35.1 No 
Right axis deviation. LVH. Early 
repolarisation II,III,avF Isolated apical 
66% / 
2.42cm/m2 
No VT on R-
test 
9 44  m No  No ltf -- T-wave inversion V3,V4,V5,V6 
Basal ant./sept.; 
Midventricular 
ant./sept.; apex 
52% / 
2.62cm/m2 No CAD 
10 31  m No  No ltf -- 
Sinus bradycardia 45 / min. Discrete 
ST segment elevation II,III,avF Isolated apical 
40% / 
3.23cm/m2 
No VT on 
Holter 
11 30  m 
Short nsVT on 
exercise stress 
test 
 No 47.8 No Normal ECG Midventricular inf/lat., inf.; apex 
56% / 
2.72cm/m2 — 
12 49   f No  No 39.1 No 
Ventricular bigeminus; non-specific 
repolarisation abnormalities Isolated apical 
50% / 
2.69cm/m2 
No VT on 
Holter 
13 48  m No Yes 77 No 
AVB III°, junctional escape rhythm 
(48 / min) 
Midventricular lat., 
inf. 
17% / 
3.89cm/m2 
NYAH II.     
No CAD 
14 20  m No  No ltf -- 
RVH. Non-specific repolarisation 
abnormalities 
Midventricular lat., 
inf., post.; apex 
74% / 
3.06cm/m2 — 
15 16 m No  No 15.3 No 
QRS 120 ms. LVH. ST segment 
depression V4,V5,V6,II,avF,I,avL. 
Preexcitation (WPW) 
Isolated apical 56% / 2.5cm/m2 — 
 
 
